Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer

Frontiers in Oncology(2021)10.3389/fonc.2020.581801Source: DataRank Database

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 1.30)OA: goldTopics (20)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Sofia R. Gameiro ORCID,Yohei Ozawa ORCID,Karin M. Knudson ORCID,Kristin C. Hicks ORCID,Claudia Palena ORCID

Live enrichment

PubMed:33747894 PMC:PMC7977003 OpenAlex:https://openalex.org/W3134009779

FWCI

1.30

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fonc.2020.581801

publisherhttps://doi.org/10.3389/fonc.2020.581801

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2020.581801/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33747894

repositoryhttps://doaj.org/article/3b635c718c7d46879728beddc14329cb

Fields of Study

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy research

Keywords

Cancer researchMedicineImmunotherapyTumor microenvironmentCytotoxic T cellImmune checkpointImmune systemImmunologyBreast cancerCancerBiologyInternal medicineTGF-βMetastatic breast cancerEntinostatBintrafusp AlfaBn-Brachyury

Sustainable Development Goals

SDG 0: Good health and well-being

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer

FAIR Checklist

Authors (15)

Impact

Open Access

Topics

Annotations (Europe PMC)